ACC 2021: Late-breaking Science Video Collection
Published: 01 June 2021
-
Views:
2524 -
Likes:
7
-
Views:
2524 -
Likes:
7
-
11m 22sPart 3 | Session 1 Findings from the WASE COVID Study: Dr Frederico M Asch
-
12m 33sPart 3 | Session 2 The Prague OCHA Study: Dr Jan Belohlavek
-
7m 15sPart 3 | Session 3 The VOYAGER PAD Trial: Dr Rupert Bauersachs
-
8m 58sPart 3 | Session 4 30-day Results of the TRISCEND Study: Dr Susheel Kodali
-
10m 38sPart 3 | Session 5 The HOLIDAY Monitors Trial: Dr Gregory Marcus
-
Part 3 | Session 6 The CONNECT-HF Trial: Dr Adam DeVore
-
15m 45sPart 3 | Session 7 The DARE-19 Randomized Trial: Dr Mikhail Kosiborod
-
10m 39sPart 3 | Session 8 The Tailor-PCI Follow-up Study: Dr Naveen Pereira
-
9m 28sPart 3 | Session 9 Findings From the RESCUE Trial: Dr Paul M Ridker
-
15m 1sPart 3 | Session 10 The SAFE-PAD Study: Dr Eric Secemsky
-
11m 45sPart 3 | Session 11 Findings From the HOST-EXAM Trial: Dr Hyo-Soo Kim
-
15m 16sPart 3 | Session 12 Findings from the RAFT-AF Trial: Dr Anthony Tang
-
33m 28sPart 1 View From the Thoraxcenter: Wrap Up of ACC 2021 Nicolas M Van Mieghem, Joost Daemen
-
16m 3sPart 2 | Session 1 The Coalition ACTION Trial: Dr Harriette Van Spall & Dr Renato Lopes Harriette Van Spall, Renato D Lopes
-
16m 20sPart 2 | Session 2 The RADIANCE-HTN TRIO Trial: Dr Harriette Van Spall & Dr Ajay J Kirtane Harriette Van Spall, Ajay J Kirtane
-
15m 2sPart 2 | Session 3 The ISCHEMIA Trial: Dr Harriette Van Spall & Dr Gregg Stone Harriette Van Spall, Gregg Stone
-
11m 30sPart 2 | Session 4 The LIFE Trial: Dr Harriette Van Spall & Dr Douglas L Mann Douglas L Mann, Harriette Van Spall
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provided a concise analysis of the late-breaking science results.
For a deeper dive into key randomized clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
The ACC. 21 Edition of Masterclass video highlighted the results of the ACC Survey on the hostile work environment.
More from this programme
Part 1
View from the Thoraxcenter: Wrap Up
Part 2
Late-breaker Discussion Series
Part 3
Expert Interviews
Part 4
Masterclass
Faculty Biographies
Steven E Nissen
Cleveland Clinic, Cleveland, US
Dr. Steven E. Nissen, an esteemed American cardiologist, researcher, and patient advocate, has left an indelible mark in the field of cardiology. Formerly the chairman of cardiovascular medicine at the renowned Cleveland Clinic in Ohio, Dr. Nissen brings a wealth of experience and expertise to his roles.
Joining the Cleveland Clinic in 1992, Dr. Nissen held key positions, including Vice-Chairman of the Department of Cardiology, Section Head of Clinical Cardiology, and Director of the Coronary Intensive Care Unit. In his most recent role, he served as the Medical Director of the Cleveland Clinic Cardiovascular Coordinating Center (C5), overseeing multi-center clinical trials. Dr. Nissen continues to contribute periodically in the Cardiac Critical Care Unit, showcasing his ongoing commitment to patient care.
A highly accomplished academic, Dr. Nissen graduated from the Webb School of California before pursuing his undergraduate degree at the University of Michigan. He…
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…